A detailed history of Wahed Invest LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Wahed Invest LLC holds 2,510 shares of REGN stock, worth $1.91 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
2,510
Previous 2,260 11.06%
Holding current value
$1.91 Million
Previous $2.38 Million 11.07%
% of portfolio
0.48%
Previous 0.48%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1024.09 - $1201.76 $256,022 - $300,440
250 Added 11.06%
2,510 $2.64 Million
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $2 Million - $2.42 Million
2,260 New
2,260 $2.38 Million
Q4 2023

Mar 11, 2024

SELL
$775.18 - $881.7 $797,660 - $907,269
-1,029 Reduced 37.07%
1,747 $1.53 Million
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $889,906 - $1.01 Million
1,148 Added 70.52%
2,776 $2.44 Million
Q3 2023

Nov 14, 2023

BUY
$692.45 - $844.37 $99,020 - $120,744
143 Added 9.63%
1,628 $1.34 Million
Q2 2023

Aug 14, 2023

BUY
$700.03 - $830.35 $107,804 - $127,873
154 Added 11.57%
1,485 $1.07 Million
Q1 2023

May 15, 2023

BUY
$680.49 - $826.97 $4,763 - $5,788
7 Added 0.53%
1,331 $1.09 Million
Q4 2022

Feb 14, 2023

BUY
$705.89 - $766.39 $100,942 - $109,593
143 Added 12.11%
1,324 $955,000
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $41,325 - $52,151
72 Added 6.49%
1,181 $814,000
Q2 2022

Aug 15, 2022

SELL
$548.35 - $738.84 $52,093 - $70,189
-95 Reduced 7.89%
1,109 $656,000
Q1 2022

May 16, 2022

BUY
$595.12 - $698.43 $2,975 - $3,492
5 Added 0.42%
1,204 $841,000
Q4 2021

Feb 14, 2022

BUY
$543.48 - $670.97 $651,632 - $804,493
1,199 New
1,199 $757,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Wahed Invest LLC Portfolio

Follow Wahed Invest LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wahed Invest LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wahed Invest LLC with notifications on news.